Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2025-12-29 @ 12:40 AM
Study NCT ID:
NCT02157103
Status:
COMPLETED
Last Update Posted:
2018-05-17
First Post:
2014-02-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
Sponsor:
Emory University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01
Start Date Type:
ACTUAL
Primary Completion Date:
2016-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-14
First Submit QC Date:
None
Study First Post Date:
2014-06-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-03-14
Results First Submit QC Date:
None
Results First Post Date:
2018-04-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-18
Last Update Post Date:
2018-05-17
Last Update Post Date Type:
ACTUAL